Drug Pipeline

PIT565 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06335979
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).		 date change Primary completion pushed: 2027-07-09 -> 2027-11-17
2026-05-30 NCT06335979
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).		 date change Completion pushed: 2027-07-09 -> 2027-11-17
2026-05-16 NCT05397496
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies		 date change Primary completion pushed: 2026-07-16 -> 2026-08-20
2026-05-16 NCT05397496
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies		 date change Completion pushed: 2026-07-16 -> 2026-08-20
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06335979 An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). Systemic Lupus Erythematosus, SLE Recruiting
NCT07029555 An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis Recruiting
NCT05397496 Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies B-cell Non-Hodgkin Lymphoma (B-NHL) Active, Not Recruiting
Sponsors Running PIT565 Trials
Novartis Pharmaceuticals (3)
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1) Non-Hodgkin Lymphoma (1) Lupus (SLE) (1) Rheumatoid Arthritis (1)
Get alerts when PIT565 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free